Indeed, it was pointed out that RF preparations are able to impair the tumor-specific in vitro cytotoxicity of cancer patients’ lymphoid cells [62,63]; IgM preparations lacking of RF anti-IgG activity, used as control, did not block the cytotoxicity, indicating that the impairing effect was the result of the specific RFs activity. The gene discussed is CD40LG; the disease is cancer.